spot_img
Thursday, May 16, 2024

Evergreen advises Tresmares Capital on its entry into Proteos Biotech

Evergreen Legal has counselled Tresmares Capital, a leading investment platform in Spain, on its entry into the shareholding of the biotechnology company Proteos Biotech

-

Proteos Biotech specialises in producing recombinant enzymes whose products have high-quality standards backed by various certifications and scientific support. The company develops exclusive assets for its customers, incorporating the latest trends and cutting-edge technology pioneered worldwide, with an international presence in more than 50 countries.

Several partners of the team have participated in this operation: Ignacio Freire and Luis Vegas in the Corporate & Commercial area, Jacobo de la Guardia in the Tax area and Cristina González Olivares in the Labour area. Associates Celia Gil and Marina Roji have also been involved.

- Advertisement -spot_img
- Advertisement -spot_img

MOST READ NEWS

Linklaters advises IVIRMA on its €3bn sale to KKR

The US fund has signed the acquisition of the Spanish company, a world leader in infertility treatments, eleven months after the transaction was announced,...

Law firm trio advises on the sale of Club Deportivo Leganés

Nebot&Páez and Mariscal Abogados have advised Moreno-Pavón Family, who until now has been Club Deportivo Leganés, S.A.D.’s majority shareholder, on the sale of 99.1%...

Pérez-Llorca, HSF advise o Peninsula Capital´s acquisition of Clínicas Dorsia

London-based Peninsula Capital has acquired a majority stake in WM Clinics, the company that owns the Dorsia, Eva and Origen brands specialising in aesthetic...
spot_img
spot_img
spot_img
spot_img
- Advertisement -spot_img
error: